Response of Second Generation Tyrosine Kinase Inhibitors in the Patients with CML at a Tertiary Care Hospital in the North Western India.

Abstract

Introduction: Chronic myeloid leukemia is characterized by the dysregulated growth of 
granulocytes, driven by the Philadelphia chromosome translocation. The prevalence of CML is 
higher in men, with a median age of 57 years and a five-year survival rate of 85%